Quick news blast: chatter today that Sanofi ($SNY) is back in discussions to acquire Ocular Therapeutix ($OCUL) (reportedly at a higher price than prior talk). $OCUL moved on the rumor — no official confirmation yet.
We’ll flag updates as they hit.
Full edition here: [https://www.biobucks.co/p/monday-epkinly-stumbles-and-the-ipo-window-cracks-open](https://www.biobucks.co/p/monday-epkinly-stumbles-and-the-ipo-window-cracks-open)
Stay up to date with our free daily biotech tape: [https://www.biobucks.co](https://www.biobucks.co)